India Capital Growth (LON:IGC) Trading Up 1.9% - Time to Buy?

Key Points

• Shares rose 1.9% on Tuesday, trading as high as GBX 153.50 and last at GBX 145.65, with approximately 154,286 shares changing hands—a decline of about 40% from average volume.
• Shore Capital Group reinstated a "house stock" rating on India Capital Growth in a report dated November 20th.
• The fund has a market capitalization of £96.98 million, a negative P/E (-14.62) and a beta of 0.70, is trading below its 50‑day (GBX 159.23) and 200‑day (GBX 167.73) moving averages, and its stated objective is long‑term capital appreciation in Indian mid/small caps while it does not hedge its Indian Rupee exposure.

Shares of India Capital Growth (LON:IGC - Get Free Report) rose 1.9% on Tuesday . The stock traded as high as GBX 153.50 and last traded at GBX 145.65. Approximately 154,286 shares changed hands during mid-day trading, a decline of 40% from the average daily volume of 255,101 shares. The stock had previously closed at GBX 143.

Analyst Upgrades and Downgrades

Separately, Shore Capital Group restated a "house stock" rating on shares of India Capital Growth in a report on Thursday, November 20th.

India Capital Growth Trading Up 1.9%

The stock has a market capitalization of £96.98 million, a price-to-earnings ratio of -14.62 and a beta of 0.70. The company has a fifty day moving average of GBX 159.23 and a two-hundred day moving average of GBX 167.73.

About India Capital Growth

Fund Objective: To provide long term capital appreciation by investing predominantly in listed mid and small cap Indian companies. Investments may also be made in large cap Indian companies where the Fund Manager believes long-term capital appreciation will be achieved. The Company may hold liquid assets (including cash) pending deployment in suitable investments. It is the Company's declared policy not to hedge the exposure to the Indian Rupee.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.